Full Text View
Tabular View
No Study Results Posted
Related Studies
Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
This study has been completed.
Study NCT00001181   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Polyostotic Fibrous Dysplasia
Precocious Puberty
Additional conditions recognized in this trial
Fibrous Dysplasia of Bone
Fibrous Dysplasia, Polyostotic
Puberty, Precocious
More general conditions related to this trial
Bone Diseases
Bone Diseases, Developmental
Endocrine System Diseases
Gonadal Disorders
Musculoskeletal Diseases
Osteochondrodysplasias
Interventions listed in this trial
Testolactone
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services